Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
29.62
Dollar change
-1.29
Percentage change
-4.17
%
Index- P/E9256.25 EPS (ttm)0.00 Insider Own0.45% Shs Outstand135.51M Perf Week-2.37%
Market Cap4.01B Forward P/E9.82 EPS next Y3.02 Insider Trans5.83% Shs Float134.90M Perf Month4.04%
Income0.80M PEG925.63 EPS next Q0.83 Inst Own95.77% Short Float / Ratio2.97% / 2.64 Perf Quarter-12.13%
Sales4.65B P/S0.86 EPS this Y23.79% Inst Trans-5.16% Short Interest4.01M Perf Half Y-12.16%
Book/sh34.97 P/B0.85 EPS next Y17.66% ROA0.10% Target Price44.67 Perf Year-6.88%
Cash/sh4.42 P/C6.71 EPS next 5Y10.00% ROE0.22% 52W Range26.81 - 40.28 Perf YTD-13.11%
Dividend1.09 P/FCF13.76 EPS past 5Y- ROI0.01% 52W High-26.46% Beta0.73
Dividend %3.68% Quick Ratio1.60 Sales past 5Y-1.76% Gross Margin35.16% 52W Low10.48% ATR0.93
Employees8900 Current Ratio2.74 Sales Q/Q2.16% Oper. Margin5.10% RSI (14)46.55 Volatility3.02% 3.44%
OptionableYes Debt/Eq0.90 EPS Q/Q129.06% Profit Margin0.02% Rel Volume2.08 Prev Close30.91
ShortableYes LT Debt/Eq0.89 EarningsNov 07 BMO Payout- Avg Volume1.52M Price29.62
Recom1.20 SMA20-1.11% SMA50-0.66% SMA200-12.59% Volume3,158,514 Change-4.17%
Date Action Analyst Rating Change Price Target Change
Nov-17-23Initiated Piper Sandler Overweight $37
Mar-07-23Initiated Canaccord Genuity Buy $49
Sep-14-22Upgrade Argus Hold → Buy $46
Sep-06-22Upgrade Wells Fargo Equal Weight → Overweight $48 → $54
Oct-14-21Upgrade Raymond James Mkt Perform → Outperform $59
Sep-30-21Upgrade Jefferies Hold → Buy $45 → $63
Apr-07-21Resumed RBC Capital Mkts Sector Perform $51
Jan-06-21Downgrade RBC Capital Mkts Outperform → Sector Perform $59 → $49
Apr-17-20Downgrade Argus Buy → Hold
Mar-24-20Upgrade JP Morgan Neutral → Overweight $57
Nov-29-23 08:54AM
Nov-28-23 01:04PM
Nov-16-23 05:16AM
Nov-15-23 05:03AM
Nov-10-23 09:16AM
02:38PM Loading…
Nov-08-23 02:38PM
Nov-07-23 02:16PM
11:53AM
09:30AM
08:56AM
07:10AM
06:47AM
06:30AM
Nov-02-23 01:39PM
Oct-31-23 11:27AM
08:54AM Loading…
08:54AM
Oct-30-23 04:35PM
Oct-24-23 09:54AM
Sep-13-23 07:14PM
Sep-11-23 04:05PM
Sep-07-23 11:30AM
Sep-01-23 09:10AM
Aug-24-23 09:41AM
Aug-08-23 11:54AM
11:00AM
08:05AM
06:56AM
06:30AM
Aug-07-23 12:09PM
Aug-02-23 10:19AM
09:31AM Loading…
Jul-25-23 09:31AM
Jul-21-23 08:50AM
Jul-14-23 11:01AM
07:35AM
Jul-13-23 05:40PM
04:31PM
03:54PM
01:58PM
11:49AM
10:50AM
10:29AM
10:15AM
09:45AM
08:43AM
08:39AM
08:38AM
08:36AM
08:21AM
Jul-12-23 09:40AM
Jul-05-23 09:40AM
Jun-30-23 09:14AM
Jun-15-23 09:40AM
Jun-14-23 09:55AM
Jun-13-23 12:49PM
12:34PM
Jun-08-23 11:31AM
07:40AM
Jun-07-23 07:47AM
Jun-06-23 12:37PM
May-31-23 10:57AM
09:35AM
May-25-23 09:40AM
May-24-23 12:53PM
10:08AM
09:09AM
May-19-23 09:40AM
May-16-23 12:00PM
10:20AM
09:02AM
06:24AM
May-14-23 10:00AM
May-10-23 05:28PM
04:32PM
02:17PM
01:40PM
01:40PM
01:24PM
May-09-23 10:30AM
10:08AM
07:55AM
06:32AM
06:30AM
May-08-23 07:05PM
May-05-23 12:08PM
11:17AM
10:49AM
May-04-23 10:00AM
08:23AM
May-01-23 11:06AM
Apr-25-23 09:18AM
Apr-06-23 08:00AM
Mar-31-23 10:36AM
Mar-28-23 10:40AM
08:58AM
Mar-27-23 07:36AM
Mar-21-23 01:01PM
Mar-20-23 02:02PM
Mar-02-23 04:01PM
12:22PM
12:07PM
Perrigo Co. Plc engages in the provision of self-care products and over-the-counter (OTC) health and wellness solutions. It enhances individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. It operates through the following segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment offers OTC solutions, infant formula, oral care, and contract manufacturing in the U.S, Mexico, and Canada. The CSCI segment includes the self-care business branded in Europe, Australia, the United Kingdom, and parts of Europe and Asia. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Willis RobertEVP & CHRONov 24Buy31.015,550172,10619,105Nov 27 07:12 PM
Ives AlisonEVP & Chief Scientific OfficerNov 16Buy29.342,04059,85410,380Nov 17 06:03 AM
Lockwood-Taylor PatrickCEONov 14Buy28.9911,000318,86811,000Nov 14 07:12 PM
Bezerra Eduardo GuaritaEVP & Chief Financial OfficerNov 14Buy29.185,000145,8828,428Nov 15 12:14 PM
Ives AlisonEVP & Chief Scientific OfficerOct 06Option Exercise30.4673822,4799,078Oct 10 08:23 AM
Manzone AlbertDirectorAug 15Option Exercise38.885,478212,9855,478Aug 17 12:48 PM
HANSON KYLEEVP & General CounselJul 07Option Exercise32.6312,409404,9069,732Jul 10 01:17 PM
Ives AlisonEVP & Chief Scientific OfficerJul 07Option Exercise32.6392030,0208,611Jul 10 01:18 PM
Parker Geoffrey M.DirectorJun 13Buy33.0610,000330,63725,879Jun 14 10:54 AM
Bezerra Eduardo GuaritaEVP & Chief Financial OfficerJun 07Option Exercise33.724,532152,8194,532Jun 09 09:38 AM
Andersen SvendEVP & President CHCIMay 23Buy33.412,90096,90268,741May 25 08:16 AM
ASHFORD ORLANDO DDirectorMay 17Option Exercise32.869,723319,49814,705May 19 02:39 PM
Parker Geoffrey M.DirectorMay 17Option Exercise32.867,778255,58519,439May 19 02:38 PM
O'Connor DonalDirectorMay 17Option Exercise32.867,778255,58524,664May 19 02:38 PM
Mann Erica LDirectorMay 17Option Exercise32.867,778255,58516,635May 19 02:37 PM
Alford Bradley ADirectorMay 17Option Exercise32.867,778255,58535,187May 19 02:37 PM
Karaboutis AdrianaDirectorMay 17Option Exercise32.867,778255,58521,656May 19 02:38 PM
KINDLER JEFFREY BDirectorMay 17Option Exercise32.867,778255,58522,184May 19 02:39 PM
Doyle Katherine C.DirectorMay 17Option Exercise32.867,778255,58514,140May 19 02:39 PM
KESSLER MURRAY SCEOMay 11Sale35.75197,6467,066,3582,668May 15 11:03 AM
Farrington ThomasEVP and CIOMar 13Sale35.573,723132,4352,823Mar 14 09:14 AM
Dillard James E IIIEVP & President CSCAMar 10Sale35.709,000321,30925,130Mar 14 09:38 AM
Janish Ronald CraigEVP, Gbl Ops & SC & CTOMar 08Sale36.924,500166,13320,191Mar 09 06:09 PM
KESSLER MURRAY SCEOMar 07Option Exercise37.7126,9941,017,944212,164Mar 08 04:56 PM
Dillard James E IIIEVP & President CSCAMar 07Option Exercise37.715,537208,80036,628Mar 08 04:55 PM
Andersen SvendEVP & President CHCIMar 07Option Exercise37.715,468206,19865,841Mar 08 04:56 PM
Janish Ronald CraigEVP, Gbl Ops & SC & CTOMar 07Option Exercise37.712,942110,94325,790Mar 08 04:56 PM
Farrington ThomasEVP and CIOMar 07Option Exercise37.712,40690,7307,705Mar 08 04:57 PM
Quinn GrainneEVP, Chief Medical OfficerMar 07Option Exercise37.712,25084,84815,233Mar 08 04:55 PM
Willis RobertEVP & CHROMar 07Option Exercise37.712,16381,56714,680Mar 08 04:55 PM
Ives AlisonEVP & Chief Scientific OfficerMar 07Option Exercise37.711,74665,8428,201Mar 09 06:20 PM
Parker Geoffrey M.DirectorMar 06Buy38.055,000190,27015,879Mar 07 07:48 AM
KESSLER MURRAY SCEOMar 03Option Exercise38.7532,9441,276,580192,158Mar 07 03:31 PM
Andersen SvendEVP & President CHCIMar 03Option Exercise38.755,951230,60160,373Mar 07 03:36 PM
Dillard James E IIIEVP & President CSCAMar 03Option Exercise38.754,675181,15632,300Mar 07 03:38 PM
Janish Ronald CraigEVP, Gbl Ops & SC & CTOMar 03Option Exercise38.753,613140,00423,622Mar 07 03:29 PM
Farrington ThomasEVP and CIOMar 03Option Exercise38.752,954114,4685,998Mar 07 03:35 PM
Quinn GrainneEVP, Chief Medical OfficerMar 03Option Exercise38.752,636102,14513,807Mar 07 03:24 PM
Willis RobertEVP & CHROMar 03Option Exercise38.752,23186,45113,183Mar 07 03:28 PM
Ives AlisonEVP & Chief Scientific OfficerMar 03Option Exercise38.752,20885,5607,090Mar 07 03:33 PM
Quinn GrainneEVP, Chief Medical OfficerDec 16Sale31.652,36874,9479,118Dec 20 07:51 AM